Editorial Standards

The Pet Treatment Index publishes in a veterinary-adjacent category where a confident mistake can affect an animal’s care and an owner’s spending. The standard is therefore not “write a thorough article.” The standard is to define the decision, identify which claims require which evidence, expose limitations, separate editorial research from clinical judgment, date mutable facts, and make correction and compensation visible.

These standards apply to editorial pages, future Treatment Records, comparisons, cost and coverage pages, data products, alerts, sponsored material, and commercial actions.

1. The reader comes before the ranking or payout

A page should exist because it resolves a real owner decision, not because a keyword can be inserted into a template.

Every proposed page must have:

• one primary searcher;
• one primary decision;
• one first-screen answer;
• one canonical entity or topic;
• one parent hub;
• original or independently verified value;
• and one legitimate next step.

If two pages answer the same decision, they should be merged. If a page would still be replaceable after the treatment name changed, it is not ready.

Revenue and ranking goals never justify a false claim, hidden limitation, misleading insurance message, experimental dosing guide, gray-market link, or duplicated page.

2. We start with the authoritative origin

The source hierarchy is:

1. Current regulator or government record. Approval databases, labels, enforcement or safety notices, official statistics, and state insurance or licensing authorities.
2. Current primary document. Policy forms, endorsements, official trial registries, regulatory filings, manufacturer labels, protocols, and formal product information.
3. Peer-reviewed target-species research. Clinical evidence in the relevant animal species and population.
4. Recognized professional guidance. Veterinary associations, consensus documents, and specialty guidance, read within their stated scope.
5. Dated provider or clinic material. Used for price, availability, service, and operational facts—not as independent proof that the provider’s treatment claim is correct.
6. High-quality secondary reporting. Used for context and to locate primary material.
7. Marketing, testimonials, social posts, and forums. Used to understand owner language, claims in circulation, or reported experiences; not used as proof of efficacy, safety, or regulatory status.

A source is not included merely to make a page look researched. Each material claim must be supported by a source capable of supporting that claim.

3. Regulatory status is specific

A status statement must identify the relevant:

• product or treatment;
• active ingredient where applicable;
• species;
• indication;
• formulation;
• route;
• and date checked.

Approval for a human product, another species, another condition, or another route is not silently extended to the use on the page. Conditional approval is not called full approval. Indexing is not called approval. A compounded preparation does not inherit the approval status of an ingredient or another finished product.

When the Editorial Desk cannot locate an official veterinary marketing status for a claimed use, the page states that limitation rather than declaring a broader legal conclusion it cannot support.

4. Evidence is classified by what it can establish

The publication separates:

• FDA-reviewed target-species evidence;
• multiple controlled target-species studies;
• limited target-species clinical evidence;
• preclinical or other-species evidence;
• anecdotal or marketing claims;
• and no meaningful evidence located.

The detailed definitions appear in the Evidence Methodology.

The central rule is simple:

We never present rodent, cell, healthy-animal, or other-species data as clinical efficacy in pets.

Mechanism, pharmacokinetic, toxicology, laboratory, and other-species findings may be important. They must be labeled for what they are.

5. Safety is not a footnote to efficacy

A record treats safety as a separate evidence question. It should identify, when supportable:

• label warnings and contraindications;
• adverse events reported in the relevant evidence;
• monitoring requirements described by authoritative sources;
• current safety communications, recalls, or label changes;
• duration and size limits of the evidence;
• and important unknowns.

The site does not turn population-level information into a personalized risk decision. An owner’s veterinarian must consider history, examination, concurrent treatment, diagnosis, and monitoring.

6. Cost claims show their denominator

A price without its unit is not a useful cost claim.

Future cost content must identify the source, location, provider type, date observed, price type, treatment or procedure, weight or dose context where relevant, one-time or recurring frequency, inclusions, exclusions, and whether the observation is posted, quoted, billed, or paid.

The publication does not create a national average from a thin convenience sample. It presents an observed range, sample size, geographic spread, and limitations.

See the Cost Data Methodology.

7. Coverage claims begin with timing and policy version

Insurance content begins by separating two situations:

• the condition, related signs, advice, or treatment need may already exist;
• the owner is planning ahead before the condition exists.

A new policy generally will not cover care tied to a pre-existing condition, although the definition and treatment of some curable conditions vary by policy and state. The publication does not imply that a quote can solve a current diagnosis.

Coverage statements identify the applicable policy form, state, version or effective date, and controlling provisions where available. “Covered” is presented as conditional, not guaranteed.

See the Insurance Coverage Methodology.

8. Clinical judgment receives a different label

Some claims can be verified editorially. Others require professional judgment.

Editorially verifiable

Examples include a current regulator status, label text, posted price, provider-stated availability, policy provision, document date, trial registry status, and whether an official source can be located.

Clinical judgment

Examples include whether a treatment is appropriate for an individual animal, how risks apply to a specific history, whether a symptom is an emergency, how to dose, whether to stop a prescribed treatment, and which alternative should be chosen.

The organizational byline does not convert editorial verification into clinical judgment.

9. Expert review is named, scoped, and earned

The publication never applies a decorative veterinary-review badge.

When expert review occurs, the page must identify:

• the reviewer’s real name;
• credential;
• relevant experience or scope;
• exact material reviewed;
• and review date.

A reviewer may correct or qualify clinical interpretation. The Editorial Desk remains responsible for pricing, commercial disclosure, partner selection, and nonclinical publication operations unless the review statement says otherwise.

A framework review does not make every page reviewed. A reviewer does not automatically endorse a commercial partner.

No licensed veterinarian review is claimed for the v1 foundation.

10. Dates mean different things

The publication distinguishes:

• Published: the page’s first public date.
• Last reviewed: the last deliberate whole-page review.
• Last verified: the last check of a mutable fact or data field.
• Source date or policy version: when the underlying document took effect or was published.

A deploy, spelling correction, or automated year change does not justify a new review date. The date changes only when the corresponding work occurred.

11. Changes and corrections are public when material

Minor grammar, formatting, and broken-link fixes may not require a public note.

A material correction should state:

• what was wrong or incomplete;
• what changed;
• why it changed;
• when it changed;
• and whether the bottom-line conclusion changed.

The publication may preserve older data versions internally. A sponsor or partner cannot veto a verified correction.

Read the Corrections Policy

12. Independence is structural

The editorial-commercial firewall is:

Revenue may change which legitimate action is offered. It may never change a treatment’s regulatory status, evidence label, safety discussion, cost methodology, or editorial conclusion.

The editorial answer is completed before a future offer is selected. Commercial links must be generated through a centralized component in later phases so that disclosure, eligibility, state limits, link attributes, and tracking rules cannot be bypassed.

No partner can purchase:

• a favorable status or evidence label;
• a ranking;
• removal of a safety fact or legitimate alternative;
• inclusion in a supposedly independent comparison without disclosure;
• a false claim of professional review;
• or suppression of a correction.

Read the Affiliate & Sponsorship Disclosure.

13. Sponsored material remains visibly separate

If sponsored research, a sponsored report, or a paid placement is introduced later:

• the sponsor is named prominently;
• the nature of payment is explained;
• the sponsored page is visually and structurally distinguished from independent editorial records;
• sponsor statements are attributed;
• methods, data sources, and limitations are visible;
• and the sponsor does not control independent status, evidence, safety, or ranking conclusions.

Native advertising that resembles an independent Treatment Record without clear disclosure is not allowed.

14. AI-assisted work is not a source

The publication may use AI-assisted tools for outlining, extraction assistance, consistency checking, coding, formatting, and generating questions for verification.

AI output cannot establish a fact. It cannot be the sole source of a citation, quotation, price, policy provision, study result, regulatory status, safety claim, or provider term. Material facts must be checked against the cited source. Clinical judgment still requires a qualified professional.

The publication, not the tool, is accountable for what appears on the page.

15. Conflicts are disclosed

A material relationship that a reasonable reader would want to know should be disclosed. Examples include:

• affiliate compensation;
• referral or booking fees;
• sponsorship;
• free products or services;
• paid research;
• data licensing;
• manufacturer or provider support;
• or a reviewer’s relevant financial relationship when known and material.

A relationship does not automatically invalidate a fact. Hiding the relationship damages trust.

16. We do not manufacture experience

The site does not claim that it personally treated animals, used a product, visited a clinic, submitted an insurance claim, or interviewed a source unless that work actually occurred and the page describes what was done.

Screenshots, support contacts, quotes, bills, estimates, and original observations are described accurately. A simulated flow is labeled simulated. A provider’s self-description is attributed to the provider.

17. We protect owner privacy

The publication does not need a pet’s medical record to explain a general treatment decision. Public forms do not ask for diagnoses, symptoms, medications, treatment plans, insurer claim files, or veterinary records.

If owner-submitted cost material is accepted in a later phase, personal, pet, provider-patient, account, and payment identifiers must be removed before use. The submission process must explain what will be retained and published.

18. We do not publish for completeness alone

A topic may remain absent when:

• primary sources are insufficient;
• the scope cannot be defined;
• the page would duplicate another decision;
• cost data is too thin to support the promised answer;
• policy variation makes a universal page misleading;
• the next action would be unsafe or illegitimate;
• maintenance requirements exceed the publication’s capacity;
• or the only monetization path would undermine the conclusion.

The absence of a page is better than a polished page that should not be trusted.

19. Removal and archiving

A page may be corrected, merged, redirected, noindexed, or removed when it is obsolete, duplicative, unsafe, unsupported, or no longer maintainable. Search traffic and partner revenue do not create a right to remain published.

When a URL has a clear successor, use an appropriate permanent redirect. When no successor exists and the page should no longer be public, return a real 404 or 410 as appropriate rather than a soft 404.

20. The standard can change

Methods should improve when evidence, law, policy, technology, or operating experience exposes a weakness. Material framework changes receive a new version date and a plain explanation.

Framework version: 1.0
Published: 2026-08-17
Last reviewed: 2026-08-17
Independent veterinary review: not yet completed. A named reviewer and review date will be shown if and when that review occurs.